These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17911166)

  • 1. Genetics of sporadic amyotrophic lateral sclerosis.
    Schymick JC; Talbot K; Traynor BJ
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R233-42. PubMed ID: 17911166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Curr Mol Med; 2009 Apr; 9(3):255-72. PubMed ID: 19355908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
    Blair IP; Williams KL; Warraich ST; Durnall JC; Thoeng AD; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.
    Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH
    Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.
    Talbot K; Ansorge O
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R182-7. PubMed ID: 16987882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal intermediate filaments and ALS: a new look at an old question.
    Xiao S; McLean J; Robertson J
    Biochim Biophys Acta; 2006; 1762(11-12):1001-12. PubMed ID: 17045786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMN1 gene, but not SMN2, is a risk factor for sporadic ALS.
    Corcia P; Camu W; Halimi JM; Vourc'h P; Antar C; Vedrine S; Giraudeau B; de Toffol B; Andres CR;
    Neurology; 2006 Oct; 67(7):1147-50. PubMed ID: 16931506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis: all roads lead to Rome.
    Gonzalez de Aguilar JL; Echaniz-Laguna A; Fergani A; René F; Meininger V; Loeffler JP; Dupuis L
    J Neurochem; 2007 Jun; 101(5):1153-60. PubMed ID: 17250677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current conceptions on etiology, pathogenesis and treatment of motor neuron disease].
    Skvortsova VI; Limborskaia SA; Levitskiĭ GN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):4-12. PubMed ID: 15704476
    [No Abstract]   [Full Text] [Related]  

  • 11. Axonal defects in mouse models of motoneuron disease.
    Jablonka S; Wiese S; Sendtner M
    J Neurobiol; 2004 Feb; 58(2):272-86. PubMed ID: 14704958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis.
    Garcia ML; Singleton AB; Hernandez D; Ward CM; Evey C; Sapp PA; Hardy J; Brown RH; Cleveland DW
    Neurobiol Dis; 2006 Jan; 21(1):102-9. PubMed ID: 16084104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Motor neuron disease].
    Niwa J; Sobue G
    Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1127-8. PubMed ID: 15168546
    [No Abstract]   [Full Text] [Related]  

  • 14. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Superoxide dismutase-1 (SOD-1) gene mutation-dependent mechanisms of neural degeneration in amyotrophic lateral sclerosis].
    Iłzecka J
    Neurol Neurochir Pol; 2001; 35(3):461-9. PubMed ID: 11732268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis.
    Gros-Louis F; Larivière R; Gowing G; Laurent S; Camu W; Bouchard JP; Meininger V; Rouleau GA; Julien JP
    J Biol Chem; 2004 Oct; 279(44):45951-6. PubMed ID: 15322088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the mechanisms involved in motor neuron degeneration in ALS.
    Bruijn LI; Miller TM; Cleveland DW
    Annu Rev Neurosci; 2004; 27():723-49. PubMed ID: 15217349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences.
    Wang XS; Lee S; Simmons Z; Boyer P; Scott K; Liu W; Connor J
    J Neurol Sci; 2004 Dec; 227(1):27-33. PubMed ID: 15546588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of amyotrophic lateral sclerosis.
    Robberecht W
    J Neurol; 2000 Dec; 247 Suppl 6():VI/2-6. PubMed ID: 19714405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.